AI assistant
Catheter Precision, Inc. — Director's Dealing 2024
Jan 10, 2024
35479_dirs_2024-01-10_4dbe4e83-0330-4587-888a-9d36a976c559.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Catheter Precision, Inc. (VTAK)
CIK: 0001716621
Period of Report: 2024-01-02
Reporting Person: Francis, John P. (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2575 | Direct |
| Common Stock | 36 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series X Convertible Preferred Stock | $ | Common Stock (11481) | Direct | ||
| Warrants (Right to Buy) | $562.50 | 2025-05-22 | Common Stock (177) | Indirect | |
| Warrants (Right to Buy) | $437.50 | 2025-08-03 | Common Stock (1371) | Indirect |
Footnotes
F1: Security is convertible no earlier than July 9, 2024, subject to satisfaction of specified conditions.
F2: Security has no expiration date.
F3: Security converts at a rate of 1000 shares of common stock per preferred share. Security has no conversion price.
F4: Securities are owned by Catalysis Partners, LLC ("CP"). The reporting person has an investment interest in CP and, together with his spouse, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager.